Cargando…

Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer

AIMS: Lymphovascular space invasion (LVSI) in endometrial cancer (EC) is an important prognostic variable impacting on a patient's individual recurrence risk and adjuvant treatment recommendations. Recent work has shown that grading the extent of LVSI further improves its prognostic strength in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peters, Elke E M, Bartosch, Carla, McCluggage, W Glenn, Genestie, Catherine, Lax, Sigurd F, Nout, Remi, Oosting, Jan, Singh, Naveena, Smit, Huub C S H, Smit, Vincent T H B M, Van de Vijver, Koen K, Bosse, Tjalling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852322/ https://www.ncbi.nlm.nih.gov/pubmed/31155736 http://dx.doi.org/10.1111/his.13871

Ejemplares similares

Incorporation of molecular characteristics into endometrial cancer management
por: Vermij, Lisa, et al.
Publicado: (2019)

Association of Lymphovascular Space Invasion (LVSI) with Histological Tumor Grade and Myometrial Invasion in Endometrial Carcinoma: A Review Study
por: Rafiee, Azita, et al.
Publicado: (2023)

Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas
por: Jamieson, Amy, et al.
Publicado: (2023)

Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility
por: Köbel, Martin, et al.
Publicado: (2019)

Performance of a HER2 testing algorithm specific for p53‐abnormal endometrial cancer
por: Vermij, Lisa, et al.
Publicado: (2021)

Reproducibility of measurement of myometrial invasion in endometrial carcinoma
por: van der Putten, Louis J. M., et al.
Publicado: (2016)

Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk Factors
por: Wortman, Bastiaan G., et al.
Publicado: (2019)

Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer
por: van Esterik, Manouk, et al.
Publicado: (2017)

Assessing Metabolic Risk Factors for LVSI in Endometrial Cancer: A Cross-Sectional Study
por: Lin, Qiaoyan, et al.
Publicado: (2022)

The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists
por: Bosse, Tjalling, et al.
Publicado: (2021)

Survey Results on Pathologic Aspects of Endocervical Adenocarcinoma by the International Society of Gynecological Pathologists
por: McCluggage, W. Glenn, et al.
Publicado: (2021)

Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer
por: Stelloo, Ellen, et al.
Publicado: (2016)

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
por: Vermij, Lisa, et al.
Publicado: (2023)

p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial
por: Vermij, Lisa, et al.
Publicado: (2022)

Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer
por: Kortekaas, Kim E., et al.
Publicado: (2020)

Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer
por: Tortorella, Lucia, et al.
Publicado: (2021)

El esquiador centrado /
por: McCluggage, Denise
Publicado: (1982)

Grading of Endocervical Adenocarcinomas: Review of the Literature and Recommendations From the International Society of Gynecological Pathologists
por: Talia, Karen L., et al.
Publicado: (2021)

Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
por: Horeweg, Nanda, et al.
Publicado: (2022)

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up
por: Colombo, Nicoletta, et al.
Publicado: (2016)

Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
por: Church, David N., et al.
Publicado: (2014)

Safety of TNF inhibitors in adolescents and children
por: McCluggage, Lauren Keyser
Publicado: (2010)

Towards developing a meaningful grading system for cervical squamous cell carcinoma
por: McCluggage, W Glenn
Publicado: (2018)

Progress in the pathological arena of gynecological cancers
por: McCluggage, W. Glenn
Publicado: (2021)

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
por: León-Castillo, Alicia, et al.
Publicado: (2020)

Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study
por: Ørtoft, Gitte, et al.
Publicado: (2019)

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
por: León‐Castillo, Alicia, et al.
Publicado: (2020)

HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes
por: Vermij, Lisa, et al.
Publicado: (2020)

Letter to the editor, Reply to: Cecile Colpaert et al.: Ultrastaging of sentinel lymph nodes in gynecological cancer: Repeating the story of breast cancer?
por: Cibula, David, et al.
Publicado: (2019)

Lymphovascular Space Invasion in Robotic Surgery for Endometrial Cancer
por: Hopkins, Mark R., et al.
Publicado: (2014)

Prediction of lymphovascular space invasion in patients with endometrial cancer
por: Kim, Sang Il, et al.
Publicado: (2021)

Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer
por: Horeweg, Nanda, et al.
Publicado: (2023)

The International Society of Gynecological Pathologists (ISGyP) Endometrial Carcinoma Project
por: McCluggage, W. Glenn, et al.
Publicado: (2019)

A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors
por: Němejcová, Kristýna, et al.
Publicado: (2023)

Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists
por: Park, Kay J., et al.
Publicado: (2021)

Interpretation of somatic POLE mutations in endometrial carcinoma
por: León‐Castillo, Alicia, et al.
Publicado: (2020)

Current Practices in the Processing, Diagnosis, and Reporting of Endometrial Carcinoma: Results of a Web-based Survey by the International Society of Gynecological Pathologists (ISGyP)
por: Parkash, Vinita, et al.
Publicado: (2019)

Hazard Ratio Analysis of Laparoscopic Radical Hysterectomy for IA1 With LVSI-IIA2 Cervical Cancer: Identifying the Possible Contraindications of Laparoscopic Surgery for Cervical Cancer
por: Li, Pengfei, et al.
Publicado: (2020)

Updates on Lymphovascular Invasion in Breast Cancer
por: Kuhn, Elisabetta, et al.
Publicado: (2023)

Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies
por: Kitson, Sarah, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ci3obbhf57649gu9a5p4r7dl64